Gene 33 inhibits apoptosis of breast cancer cells and increases poly(ADP-ribose) polymerase expression Jie XuAdam B. KeetonJoseph L. Messina OriginalPaper Pages: 207 - 215
Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy Marianne RybergDorte NielsenPer Dombernowsky OriginalPaper Pages: 217 - 225
Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer E. V. MoiseevaE. M. RapoportW. Den Otter OriginalPaper Pages: 227 - 241
Racial disparities in treatment and survival of women with stage I–III breast cancer at a large academic medical center in metropolitan Detroit Wei DuMichael S. Simon Report Pages: 243 - 248
Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients Susan A. NowellJiyoung AhnChristine B. Ambrosone Report Pages: 249 - 258
PKCδ and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells Amy M. Mingo-SionHeather A. FergusonCarla L. Van Den Berg Report Pages: 259 - 269
Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells Carsten T. ViehlYoshiyuki TanakaPeter S. Goedegebuure OriginalPaper Pages: 271 - 278
The benefit of participating to clinical research N. Hébert-CroteauJ. BrissonJ. Latreille Brief communication Pages: 279 - 281
Breast reduction and cancer in the gland remnant: a review Beniamino PalmieriAlberto CostaGiorgia Benuzzi OriginalPaper Pages: 283 - 290